Cargando…
Landscape of DILI-related adverse drug reaction in China Mainland
Drug-induced liver injury (DILI) is a type of bizarre adverse drug reaction (ADR) damaging liver (L-ADR) which may lead to substantial hospitalizations and mortality. Due to the general low incidence, detection of L-ADR remains an unsolved public health challenge. Therefore, we used the data of 6.67...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764066/ https://www.ncbi.nlm.nih.gov/pubmed/36561993 http://dx.doi.org/10.1016/j.apsb.2022.04.019 |
_version_ | 1784853196579012608 |
---|---|
author | Wang, Jiabo Song, Haibo Ge, Feilin Xiong, Peng Jing, Jing He, Tingting Guo, Yuming Shi, Zhuo Zhou, Chao Han, Zixin Han, Yanzhong Niu, Ming Bai, Zhaofang Luo, Guangbin Shen, Chuanyong Xiao, Xiaohe |
author_facet | Wang, Jiabo Song, Haibo Ge, Feilin Xiong, Peng Jing, Jing He, Tingting Guo, Yuming Shi, Zhuo Zhou, Chao Han, Zixin Han, Yanzhong Niu, Ming Bai, Zhaofang Luo, Guangbin Shen, Chuanyong Xiao, Xiaohe |
author_sort | Wang, Jiabo |
collection | PubMed |
description | Drug-induced liver injury (DILI) is a type of bizarre adverse drug reaction (ADR) damaging liver (L-ADR) which may lead to substantial hospitalizations and mortality. Due to the general low incidence, detection of L-ADR remains an unsolved public health challenge. Therefore, we used the data of 6.673 million of ADR reports from January 1st, 2012 to December 31st, 2016 in China National ADR Monitoring System to establish a new database of L-ADR reports for future investigation. Results showed that totally 114,357 ADR reports were retrieved by keywords searching of liver-related injuries from the original heterogeneous system. By cleaning and standardizing the data fields by the dictionary of synonyms and English translation, we resulted 94,593 ADR records reported to liver injury and then created a new database ready for computer mining. The reporting status of L-ADR showed a persistent 1.62-fold change over the past five years. The national population-adjusted reporting numbers of L-ADR manifested an upward trend with age increasing and more evident in men. The annual reporting rate of L-ADR in age group over 80 years old strikingly exceeded the annual DILI incidence rate in general population, despite known underreporting situation in spontaneous ADR reporting system. The percentage of herbal and traditional medicines (H/TM) L-ADR reports in the whole number was 4.5%, while 80.60% of the H/TM reports were new findings. There was great geographical disparity of reported agents, i.e. more cardiovascular and antineoplastic agents were reported in higher socio-demographic index (SDI) regions and more antimicrobials, especially antitubercular agents, were reported in lower SDI regions. In conclusion, this study presented a large-scale, unbiased, unified, and computer-minable L-ADR database for further investigation. Age-, sex- and SDI-related risks of L-ADR incidence warrant to emphasize the precise pharmacovigilance policies within China or other regions in the world. |
format | Online Article Text |
id | pubmed-9764066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-97640662022-12-21 Landscape of DILI-related adverse drug reaction in China Mainland Wang, Jiabo Song, Haibo Ge, Feilin Xiong, Peng Jing, Jing He, Tingting Guo, Yuming Shi, Zhuo Zhou, Chao Han, Zixin Han, Yanzhong Niu, Ming Bai, Zhaofang Luo, Guangbin Shen, Chuanyong Xiao, Xiaohe Acta Pharm Sin B Original Article Drug-induced liver injury (DILI) is a type of bizarre adverse drug reaction (ADR) damaging liver (L-ADR) which may lead to substantial hospitalizations and mortality. Due to the general low incidence, detection of L-ADR remains an unsolved public health challenge. Therefore, we used the data of 6.673 million of ADR reports from January 1st, 2012 to December 31st, 2016 in China National ADR Monitoring System to establish a new database of L-ADR reports for future investigation. Results showed that totally 114,357 ADR reports were retrieved by keywords searching of liver-related injuries from the original heterogeneous system. By cleaning and standardizing the data fields by the dictionary of synonyms and English translation, we resulted 94,593 ADR records reported to liver injury and then created a new database ready for computer mining. The reporting status of L-ADR showed a persistent 1.62-fold change over the past five years. The national population-adjusted reporting numbers of L-ADR manifested an upward trend with age increasing and more evident in men. The annual reporting rate of L-ADR in age group over 80 years old strikingly exceeded the annual DILI incidence rate in general population, despite known underreporting situation in spontaneous ADR reporting system. The percentage of herbal and traditional medicines (H/TM) L-ADR reports in the whole number was 4.5%, while 80.60% of the H/TM reports were new findings. There was great geographical disparity of reported agents, i.e. more cardiovascular and antineoplastic agents were reported in higher socio-demographic index (SDI) regions and more antimicrobials, especially antitubercular agents, were reported in lower SDI regions. In conclusion, this study presented a large-scale, unbiased, unified, and computer-minable L-ADR database for further investigation. Age-, sex- and SDI-related risks of L-ADR incidence warrant to emphasize the precise pharmacovigilance policies within China or other regions in the world. Elsevier 2022-12 2022-05-06 /pmc/articles/PMC9764066/ /pubmed/36561993 http://dx.doi.org/10.1016/j.apsb.2022.04.019 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Wang, Jiabo Song, Haibo Ge, Feilin Xiong, Peng Jing, Jing He, Tingting Guo, Yuming Shi, Zhuo Zhou, Chao Han, Zixin Han, Yanzhong Niu, Ming Bai, Zhaofang Luo, Guangbin Shen, Chuanyong Xiao, Xiaohe Landscape of DILI-related adverse drug reaction in China Mainland |
title | Landscape of DILI-related adverse drug reaction in China Mainland |
title_full | Landscape of DILI-related adverse drug reaction in China Mainland |
title_fullStr | Landscape of DILI-related adverse drug reaction in China Mainland |
title_full_unstemmed | Landscape of DILI-related adverse drug reaction in China Mainland |
title_short | Landscape of DILI-related adverse drug reaction in China Mainland |
title_sort | landscape of dili-related adverse drug reaction in china mainland |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764066/ https://www.ncbi.nlm.nih.gov/pubmed/36561993 http://dx.doi.org/10.1016/j.apsb.2022.04.019 |
work_keys_str_mv | AT wangjiabo landscapeofdilirelatedadversedrugreactioninchinamainland AT songhaibo landscapeofdilirelatedadversedrugreactioninchinamainland AT gefeilin landscapeofdilirelatedadversedrugreactioninchinamainland AT xiongpeng landscapeofdilirelatedadversedrugreactioninchinamainland AT jingjing landscapeofdilirelatedadversedrugreactioninchinamainland AT hetingting landscapeofdilirelatedadversedrugreactioninchinamainland AT guoyuming landscapeofdilirelatedadversedrugreactioninchinamainland AT shizhuo landscapeofdilirelatedadversedrugreactioninchinamainland AT zhouchao landscapeofdilirelatedadversedrugreactioninchinamainland AT hanzixin landscapeofdilirelatedadversedrugreactioninchinamainland AT hanyanzhong landscapeofdilirelatedadversedrugreactioninchinamainland AT niuming landscapeofdilirelatedadversedrugreactioninchinamainland AT baizhaofang landscapeofdilirelatedadversedrugreactioninchinamainland AT luoguangbin landscapeofdilirelatedadversedrugreactioninchinamainland AT shenchuanyong landscapeofdilirelatedadversedrugreactioninchinamainland AT xiaoxiaohe landscapeofdilirelatedadversedrugreactioninchinamainland |